Sources suggested that until systems improve, an animator could use motion synthesis to speed up blocking, a typical ...

The success of most peptide and protein drugs is dependent upon the delivery of the biologically active form to the site of action. In the design and development of formulations to achieve this goal, ...

To answer these challenges, we have developed a prototype hybrid intelligent system for automatic drug formulation. This system consists of a rule-based Expert System (ES) that conducts formulation ...

Evaluation of the design shows that there is a strong correlation between the extragranular excipient composition of a formulation in addition to the process variable of mixing time and the granule ...

Electronic Design Automation (EDA) is a suite of software and hardware tools used to design, simulate, verify, and optimize electronic systems and semiconductor chips. It enables engineers to create ...

A simple, sensitive, precise, accurate and robust high performance liquid chromatographic method has been developed for simultaneous estimation of saxagliptin (SAXA) and dapagliflozin (DAPA) in ...

amorphous solid dispersions machine learning dissolution kinetic formulation design Read this article To access this article, please review the available access options below.

A Gorilla Animation Rig for Blender Made in Blender 3.6.2 This Blender file includes: Gorilla Tag Player Model Gorilla Tag Player Textures (Fur, Lava, Rock, Ice) (New updated textures) Custom Ik ...

Does your outdoor space need a makeover? Maybe you’ve been researching landscape design ideas and are considering hiring a landscape architect or designer. Maybe you hope to learn more about the ...

Lisinopril is an orally active angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension, heart failure, and acute myocardial infarction.

Characterization of an Extemporaneous Liquid Formulation of Lisinopril Karen C. Thompson, Zhongxi Zhao, Jessica M. Mazakas, Christopher A. Beasley, Robert A. Reed, Cheryl L. Moser Disclosures ...